Edition:
United Kingdom

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

12.20USD
20 Sep 2018
Change (% chg)

$1.15 (+10.41%)
Prev Close
$11.05
Open
$11.50
Day's High
$12.31
Day's Low
$11.49
Volume
41,799
Avg. Vol
29,467
52-wk High
$14.50
52-wk Low
$5.50

Chart for

About

Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029... (more)

Overall

Beta: -0.25
Market Cap(Mil.): ¥52,650.22
Shares Outstanding(Mil.): 41.88
Dividend: --
Yield (%): --

Financials

  MNOV.OQ Industry Sector
P/E (TTM): -- 107.68 32.65
EPS (TTM): -40.69 -- --
ROI: -24.00 1.61 12.72
ROE: -25.23 0.32 14.84

BRIEF-MediciNova to collaborate with UCLA researchers in grant-funded clinical trial of MN-166 (ibudilast) in alcohol use disorder and withdrawal

* Says it plans to initiate a clinical trial of MN-166 (ibudilast) in alcohol dependence and withdrawal in collaboration with researchers at the University of California, Los Angeles (UCLA)

08 May 2018

Earnings vs. Estimates